MNI BRIEF: China To Strengthen Policy Easing In 2025: Poliburo

MNI BRIEF: Japan Nov Sentiment, Outlook Indexes Rise

MNI BRIEF: China Nov CPI Slows To 5-Month Low Of 0.2% Y/Y

MNI: PBOC Sets Yuan Parity Higher At 7.1870 Mon; -1.39% Y/Y

MNI: China CFETS Yuan Index Down 0.36% In Week of Dec 6

MNI: PBOC Net Injects CNY13.8 Bln via OMO Monday

MNI JAPAN Q3 GDP REV +0.3% Q/Q; PRELIM +0.2%; MEDIAN +0.2%

MNI: UNIV OF MICHIGAN CONSUMER SENTIMENT PRELIMINARY DEC INDEX 74.0

CANADA NOV IVEY PURCHASING MANAGERS INDEX 52.3 SA

MNI EXCLUSIVE: EU-Mercosur Deal Close, But Likely Short-Lived - Officials

AUSTRALIA: 2025 Election Outcome Looking More Uncertain According To Newspoll

© 1982-2024 MNI. All rights reserved.
Terms | Privacy
Log Out
Free Trial

$15B Abbvie 7Pt Jumbo Launched, $5B Larger Than Immunogen Deal

PIPELINE

Abbvie's $15B 7-tranche issuance is appr $5B larger than the amount paid for Immunogen: according to Abbvie, the transaction was "valued at $31.26 per share in cash, for a total equity value of approximately $10.1B." Needless to say, market eager to provide the capital with the order book growing over $80B before the launch.

  • Date $MM Issuer (Priced *, Launch #)
  • 2/22 $15B #Abbvie** $2.25B 3Y +35, $2.5B 5Y +50, $2B 7Y +60, $3B 10Y +75, $750M 20Y +75, $3B 30Y +95, $1.5B 40Y +105
  • 2/22 $2B *Federal Rep of Germany (KFW) 10Y +51
  • 2/22 $2B #BNG Bank 3Y SOFR +32
  • 2/22 $1.7B #Exelon $650M 5Y +87.5, $650M 10Y +115, $400M 29Y +130
  • 2/22 $1B Royal Caribbean 8NC3
  • 2/22 $700M #Northern States WNG 30Y +97
  • 2/22 $2B #Caterpillar $800M 2Y +35, $600M 2Y SOFR+46, $600M 5Y +55
  • 2/22 $Benchmark Panama 7Y 8%a, 13Y 8.5%a, 33Y 8.75%a
  • **Abbvie held investor calls yesterday after filing funding offer to fund Immunogen deal. For historical context, back on November 12, 2019, Abbvie issued $30B debt over 10 tranches
BulletMarketsFixed Income BulletsHomepage
BulletMarketsFixed Income BulletsHomepage

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.